POS1017 Guselkumab Provides Continued Improvement In Key Domains Of Psoriatic Arthritis Through 2 Years

Coates, L., Gossec, L., Contre, C. et al. (8 more authors) (2022) POS1017 Guselkumab Provides Continued Improvement In Key Domains Of Psoriatic Arthritis Through 2 Years. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 818-819.

Metadata

Authors/Creators:
  • Coates, L.
  • Gossec, L.
  • Contre, C.
  • Shawi, M.
  • Rampakakis, E.
  • Shiff, N.
  • Kollmeier, A.
  • Xu, X.L.
  • Nash, P.
  • Mease, P.J.
  • Helliwell, P.
Dates:
  • Published (online): 23 May 2022
  • Published: 23 May 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 22 Aug 2023 12:56
Last Modified: 22 Aug 2023 12:56
Status: Published
Publisher: BMJ
Identification Number: https://doi.org/10.1136/annrheumdis-2022-eular.902
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)